Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) MAD Oral Device Market Research Report 2019-2025

Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on MAD Oral Device Industry
  • 1.7 COVID-19 Impact: MAD Oral Device Market Trends
  • 2 Global MAD Oral Device Quarterly Market Size Analysis

    • 2.1 MAD Oral Device Business Impact Assessment - COVID-19
      • 2.1.1 Global MAD Oral Device Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global MAD Oral Device Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global MAD Oral Device Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global MAD Oral Device Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global MAD Oral Device Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers MAD Oral Device Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into MAD Oral Device Market
    • 3.5 Key Manufacturers MAD Oral Device Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on MAD Oral Device Segments, By Type

    • 4.1 Introduction
      • 1.4.1 One Piece Device
      • 1.4.2 Two Piece Devices
    • 4.2 By Type, Global MAD Oral Device Market Size, 2019-2021
      • 4.2.1 By Type, Global MAD Oral Device Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global MAD Oral Device Price, 2020-2021

    5 Impact of Covid-19 on MAD Oral Device Segments, By Application

    • 5.1 Overview
      • 5.5.1 Mild to Moderate OSA
      • 5.5.2 Severe OSA
    • 5.2 By Application, Global MAD Oral Device Market Size, 2019-2021
      • 5.2.1 By Application, Global MAD Oral Device Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global MAD Oral Device Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 ResMed
      • 7.1.1 ResMed Business Overview
      • 7.1.2 ResMed MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.1.3 ResMed MAD Oral Device Product Introduction
      • 7.1.4 ResMed Response to COVID-19 and Related Developments
    • 7.2 SomnoMed
      • 7.2.1 SomnoMed Business Overview
      • 7.2.2 SomnoMed MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.2.3 SomnoMed MAD Oral Device Product Introduction
      • 7.2.4 SomnoMed Response to COVID-19 and Related Developments
    • 7.3 Tomed GmbH
      • 7.3.1 Tomed GmbH Business Overview
      • 7.3.2 Tomed GmbH MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.3.3 Tomed GmbH MAD Oral Device Product Introduction
      • 7.3.4 Tomed GmbH Response to COVID-19 and Related Developments
    • 7.4 OSCIMED SA
      • 7.4.1 OSCIMED SA Business Overview
      • 7.4.2 OSCIMED SA MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.4.3 OSCIMED SA MAD Oral Device Product Introduction
      • 7.4.4 OSCIMED SA Response to COVID-19 and Related Developments
    • 7.5 Glidewell Laboratories
      • 7.5.1 Glidewell Laboratories Business Overview
      • 7.5.2 Glidewell Laboratories MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.5.3 Glidewell Laboratories MAD Oral Device Product Introduction
      • 7.5.4 Glidewell Laboratories Response to COVID-19 and Related Developments
    • 7.6 SCHEU
      • 7.6.1 SCHEU Business Overview
      • 7.6.2 SCHEU MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.6.3 SCHEU MAD Oral Device Product Introduction
      • 7.6.4 SCHEU Response to COVID-19 and Related Developments
    • 7.7 Oasys Sleep
      • 7.7.1 Oasys Sleep Business Overview
      • 7.7.2 Oasys Sleep MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.7.3 Oasys Sleep MAD Oral Device Product Introduction
      • 7.7.4 Oasys Sleep Response to COVID-19 and Related Developments
    • 7.8 Aurum Group
      • 7.8.1 Aurum Group Business Overview
      • 7.8.2 Aurum Group MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.8.3 Aurum Group MAD Oral Device Product Introduction
      • 7.8.4 Aurum Group Response to COVID-19 and Related Developments
    • 7.9 aveoTSD
      • 7.9.1 aveoTSD Business Overview
      • 7.9.2 aveoTSD MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.9.3 aveoTSD MAD Oral Device Product Introduction
      • 7.9.4 aveoTSD Response to COVID-19 and Related Developments
    • 7.10 Keller Dental Lab
      • 7.10.1 Keller Dental Lab Business Overview
      • 7.10.2 Keller Dental Lab MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.10.3 Keller Dental Lab MAD Oral Device Product Introduction
      • 7.10.4 Keller Dental Lab Response to COVID-19 and Related Developments
    • 7.11 Myerson
      • 7.11.1 Myerson Business Overview
      • 7.11.2 Myerson MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.11.3 Myerson MAD Oral Device Product Introduction
      • 7.11.4 Myerson Response to COVID-19 and Related Developments
    • 7.12 Respire Medical
      • 7.12.1 Respire Medical Business Overview
      • 7.12.2 Respire Medical MAD Oral Device Quarterly Production and Revenue, 2020
      • 7.12.3 Respire Medical MAD Oral Device Product Introduction
      • 7.12.4 Respire Medical Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 MAD Oral Device Supply Chain Analysis
      • 8.1.1 MAD Oral Device Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on MAD Oral Device Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 MAD Oral Device Distribution Channels
      • 8.2.2 Covid-19 Impact on MAD Oral Device Distribution Channels
      • 8.2.3 MAD Oral Device Distributors
    • 8.3 MAD Oral Device Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of MAD Oral Device, including the following market information:
      Global MAD Oral Device Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global MAD Oral Device Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global MAD Oral Device Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global MAD Oral Device Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include ResMed, SomnoMed, Tomed GmbH, OSCIMED SA, Glidewell Laboratories, SCHEU, Oasys Sleep, Aurum Group, aveoTSD, Keller Dental Lab, Myerson, Respire Medical, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      One Piece Device
      Two Piece Devices

      Based on the Application:
      Mild to Moderate OSA
      Severe OSA

      Buy now